Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Montara Therapeutics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Montara Therapeutics's investors include Dementia Discovery Fund, KdT Ventures, Michael J. Fox Foundation, Two Bear Capital, BEVC.
Montara Therapeutics is headquartered in San Francisco, United States.
Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Montara Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Montara Therapeutics — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/montara-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Montara Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/montara-therapeutics
{{cite web |title=Montara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/montara-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated